Novavax, Inc.
NVAX
Market Cap$2.02B
Close$
$24.78
90.5% upside
Current Fair Value
90.5% upsideUndervalued by 90.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.02 Billion |
|---|---|
| Enterprise Value | $1.68 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-5.41 |
| Beta | 0.0 |
| Outstanding Shares | 140,403,554 |
| Avg 30 Day Volume | 14,621,226 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.71 |
|---|---|
| PEG | 175.13 |
| Price to Sales | 1.86 |
| Price to Book Ratio | -2.17 |
| Enterprise Value to Revenue | 1.71 |
| Enterprise Value to EBIT | -2.97 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | -0.32 |
Revenue Sources
No data
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck